Evidence map›Paper›PMID 30333319›Full record

ArticleJCI insight2018

Influenza-mediated reduction of lung epithelial ion channel activity leads to dysregulated pulmonary fluid homeostasis.

Jeffrey D Brand, Ahmed Lazrak, John E Trombley, Ren-Jay Shei, A Timothy Adewale, Jennifer L Tipper, Zhihong Yu, Amit R Ashtekar, Steven M Rowe, Sadis Matalon and 1 more

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 63 citations in OpenAlex.

  1. Trial
  2. Article
  3. mBio · 2026
    Article
  4. Don't Stress: We're One Step Closer to Host-Directed Therapy for Influenza.American journal of respiratory cell and molecular biology · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Mechanisms of impaired alveolar fluid clearance.Anatomical record (Hoboken, N.J. : 2007) · 2025
    Review
  9. CFTR as a therapeutic target for severe lung infection.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Jeffrey D BrandDepartment of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine.
Ahmed LazrakDepartment of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine.
John E TrombleyDepartment of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine.
Ren-Jay SheiDepartment of Medicine, Division of Pulmonary, Allergy, and Critical Care, and.
A Timothy AdewaleGregory Fleming James Cystic Fibrosis Research Center, School of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA.
Jennifer L TipperDepartment of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine.
Zhihong YuDepartment of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine.
Amit R AshtekarDepartment of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine.
Steven M RoweDepartment of Medicine, Division of Pulmonary, Allergy, and Critical Care, and.
Sadis MatalonDepartment of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine.
Kevin S HarrodDepartment of Anesthesiology and Perioperative Medicine, Division of Molecular and Translational Biomedicine.
University of Alabama at Birmingham · US

Funding

UAB CF Research and Translation Core CenterP30DK072482 · NIDDK · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Brian R. Davis · 2007 to 2026
$23.0M
Translational Program in CFTR-Related Airway DiseasesR35HL135816 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ROWE, STEVEN MARK · 2017 to 2022
$6.3M
Training Program in Lung Biology and Translational MedicineT32HL105346 · NHLBI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI GAGGAR, AMIT · 2010 to 2025
$5.0M
Targeting MMP9 to Improve Outcomes in Serious Influenza InfectionsR01AI111475 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI HARROD, KEVIN S, LEVY, BRUCE D · 2014 to 2018
$4.3M
Bromine Inhalation Induced Lung Injury: Novel Mechanisms and Treatment StrategiesU01ES026458 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI MATALON, SADIS · 2015 to 2019
$3.9M
CIALIS® reverses halogen induced injury to pregnant animals and their offspringU01ES027697 · NIEHS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI JILLING, TAMAS SANDOR, MATALON, SADIS · 2016 to 2020
$3.7M
NHLBI NIH HHS R35 HL135816NHLBI NIH HHS T32 HL105346NIAID NIH HHS R01 AI111475NIDDK NIH HHS P30 DK072482NIEHS NIH HHS U01 ES026458NIEHS NIH HHS U01 ES027697
6 · The paper itself

Abstract

Severe influenza (IAV) infection can develop into bronchopneumonia and edema, leading to acquired respiratory distress syndrome (ARDS) and pathophysiology. Underlying causes for pulmonary edema and aberrant fluid regulation largely remain unknown, particularly regarding the role of viral-mediated mechanisms. Herein, we show that distinct IAV strains reduced the functions of the epithelial sodium channel (ENaC) and the cystic fibrosis transmembrane regulator (CFTR) in murine respiratory and alveolar epithelia in vivo, as assessed by measurements of nasal potential differences and single-cell electrophysiology. Reduced ion channel activity was distinctly limited to virally infected cells in vivo and not bystander uninfected lung epithelium. Multiple lines of evidence indicated ENaC and CFTR dysfunction during the acute infection period; however, only CFTR dysfunction persisted beyond the infection period. ENaC, CFTR, and Na,K-ATPase activities and protein levels were also reduced in virally infected human airway epithelial cells. Reduced ENaC and CFTR led to changes in airway surface liquid morphology of human tracheobronchial cultures and airways of IAV-infected mice. Pharmacologic correction of CFTR function ameliorated IAV-induced physiologic changes. These changes are consistent with mucous stasis and pulmonary edema; furthermore, they indicate that repurposing therapeutic interventions correcting CFTR dysfunction may be efficacious for treatment of IAV lung pathophysiology.

Indexed as

AminopyridinesAnimalsBenzodioxolesBronchiCells, CulturedCystic Fibrosis Transmembrane Conductance RegulatorDisease Models, AnimalDogsEpithelial CellsEpithelial Sodium ChannelsFemaleHumansInfluenza A virusInfluenza, HumanMadin Darby Canine Kidney CellsMaleAminopyridinesBenzodioxolesCFTR protein, humanCftr protein, mouseCystic Fibrosis Transmembrane Conductance RegulatorEpithelial Sodium ChannelslumacaftorSodium-Potassium-Exchanging ATPaseEpithelial transport of ions and waterInfluenzaPulmonologyVirology

Identifiers

PMID30333319
PMCPMC6237450
OpenAlexW2897146785

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.